Yarbrough Capital, LLC
- SEC CIK
- 0001767686
- Latest filing
- Aug 10, 2026
RCKT holding history
Rocket Pharmaceuticals, Inc. in every 13F filed by Yarbrough Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RCKT overviewAll 13F holders of RCKTFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −19,531−100.0% | Sold out | Holders |
| Q1 2025 | 19,531 | $130.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 19,531 | $245.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 19,531 | $360.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 19,531 | $420.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 19,531 | $526.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 19,531 | $585.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 19,531 | $400.2K | <0.1% | +19,531 | New | Holders |